Angiotensin(1-7) and ACE2, "The Hot Spots" of Renin-Angiotensin System, Detected in the Human Aqueous Humor

被引:58
作者
Holappa, Mervi [1 ]
Valjakka, Jarkko [1 ]
Vaajanen, Anu [2 ,3 ]
机构
[1] Univ Tampere, BioMediTech, Tampere, Finland
[2] Tampere Univ Hosp, Dept Ophthalmol, POB 2000, Tampere 33521, Finland
[3] Univ Tampere, Sch Med, Dept Ophthalmol, SILK, Tampere, Finland
关键词
Angiotensin (1-7); angiotensin converting enzyme 2; angiotensin II; angiotensin converting enzyme 1; aqueous humor; glaucoma; renin-angiotensin system;
D O I
10.2174/1874364101509010028
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Background: The main purpose of the study was to establish whether essential components of the reninangiotensin system (RAS) exist in the human aqueous humor. Methods: Forty-five patients >= 60 (74 +/- 7) years of age undergoing cataract surgery at Tampere University Hospital were randomly selected for the prospective study. The exclusion criterion was the use of oral antihypertensive medicine acting via renin-angiotensin system. Aqueous humor samples were taken at the beginning of normal cataract extraction. The samples were frozen and stored at -80 degrees C. The concentrations of intraocular endogenous RAS components Ang(1-7), ACE2, and ACE1 were measured using ELISA. Results: Concentration medians of Ang(1-7), ACE2, and ACE1 in the aqueous humor were: Ang(1-7) 4.08 ng/ml, ACE2 2.32 ng/ml and ACE1 0.35 ng/ml. The concentrations were significantly higher in glaucomatous than in non-glaucomatous eyes, ACE1 (p=0.014) and Ang(1-7) (p=0.026) vs non-glaucomatous eyes. Conclusions: Ang(1-7), ACE2 and ACE1 are found in the human aqueous humor. The observations are consistent with the conception that local tissue-RAS exists in the human eye and it might have a role in the control of intraocular pressure.
引用
收藏
页码:28 / 32
页数:5
相关论文
共 25 条
[1]  
Costagliola C, 1995, Eur J Ophthalmol, V5, P19
[2]   Effect of oral losartan potassium administration on intraocular pressure in normotensive and glaucomatous human subjects [J].
Costagliola, C ;
Verolino, M ;
De Rosa, ML ;
Iaccarino, G ;
Ciancaglini, M ;
Mastropasqua, L .
EXPERIMENTAL EYE RESEARCH, 2000, 71 (02) :167-171
[3]  
DANSER AHJ, 1994, INVEST OPHTH VIS SCI, V35, P1008
[4]  
Ferrao Fernanda M, 2014, World J Nephrol, V3, P64, DOI 10.5527/wjn.v3.i3.64
[5]   Renin-angiotensin system revisited [J].
Fyhrquist, F. ;
Saijonmaa, O. .
JOURNAL OF INTERNAL MEDICINE, 2008, 264 (03) :224-236
[6]   INTRAOCULAR-PRESSURE LOWERING EFFECTS OF THE RENIN INHIBITOR ABBOTT-64662 DIACETATE IN ANIMALS [J].
GIARDINA, WJ ;
KLEINERT, HD ;
EBERT, DM ;
WISMER, CT ;
CHEKAL, MA ;
STEIN, HH .
JOURNAL OF OCULAR PHARMACOLOGY, 1990, 6 (02) :75-83
[7]   The ocular renin-angiotensin system: A therapeutic target for the treatment of ocular disease [J].
Giese, Michael J. ;
Speth, Robert C. .
PHARMACOLOGY & THERAPEUTICS, 2014, 142 (01) :11-32
[8]   The effect of topical CS-088, an angiotensin AT1 receptor antagonist, on intraocular pressure and aqueous humor dynamics in rabbits [J].
Inoue, T ;
Yokoyama, T ;
Mori, Y ;
Sasaki, Y ;
Hosokawa, T ;
Yanagisawa, H ;
Koike, H .
CURRENT EYE RESEARCH, 2001, 23 (02) :133-138
[9]   Systemic Medication and Intraocular Pressure in a British Population The EPIC-Norfolk Eye Study [J].
Khawaja, Anthony P. ;
Chan, Michelle P. Y. ;
Broadway, David C. ;
Garway-Heath, David F. ;
Luben, Robert ;
Yip, Jennifer L. Y. ;
Hayat, Shabina ;
Wareham, Nicholas J. ;
Khaw, Kay-Tee ;
Foster, Paul J. .
OPHTHALMOLOGY, 2014, 121 (08) :1501-1507
[10]  
Kramkowski K, 2006, J PHYSIOL PHARMACOL, V57, P529